- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03285529
The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty
Study Overview
Detailed Description
Preclinical and biomechanical studies have demonstrated efficacy in cosmetic skin and deep tissue closures.[1], [2] In addition, barbed sutures have been shown to provide water-tight closure and wound strength comparable to or superior to closure with conventional sutures. Many comparative studies have been published contrasting barbed sutures to conventional closure techniques in multiple surgical fields. [3], [4] Various studies have evaluated the outcomes of different barbed suture devices, however there are no reports assessing the length of closure times using STRATAFIX (Ethicon, Johnson and Johnson, Somerville, New Jersey) Knotless Tissue Control Devices during deep closure in total hip arthroplasty. Stephens et al. [5] performed a prospective randomized study of 500 total knee arthroplasty patients who received either barbed suture (250) or conventional sutures (250) for deep closure of the surgical wound. The mean operating time was significantly shorter in the barbed group as compared to conventional group (64.3 vs 68.1 minutes, p=<0.001). In a study of 80 TKA (61 barbed, 19 conventional deep sutures) and 54 THA patients (37 barbed, 17 conventional deep sutures), Smith et al. [6] found significantly shorter closure time in the barbed suture group (16.78 vs. 26.5 minutes, p<0.001). One study reports one the use of Stratfix suture for intracorporeal suturing in myomectomy. Giampaolino et al. [7] performed a prospective randomized study on 47 patients and evaluated the mean operative time for laparoscopic posterior myomectomy using Stratafix or conventional suture for intracorporeal suturing. There was a significant decrease in mean operative time associated with use of Stratafix suture as compared to conventional suture (66.3 vs 73 minutes, p=0.005).
This prospective randomized single-center study will examine the outcomes, mainly closure time, of deep closure during total knee arthroplasty using the STRATAFIX Symmetric PDS Plus (Ethicon, Johnson and Johnson, Somerville, New Jersey) barbed suture compared to interrupted VICRYL suture (Ethicon, Johnson and Johnson, Somerville, New Jersey).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Males and females, between the ages of 18 to 80 years at the time of signing the informed consent document.
- Understand and voluntarily sign an informed consent document prior to any study-related assessments/procedures are conducted.
- Able to adhere to the study visit schedule and other protocol requirements.
- Able to fluently speak and understand the local language
- If female, is non-pregnant (negative pregnancy test results at the baseline/randomization visit) and non-lactating.
- End-stage osteoarthritis patients planning to undergo primary total knee arthroplasty
- BMI less than 40 kg/m2
Exclusion Criteria:
- BMI greater than or equal to 40 kg/m2.
- History of known bleeding disorder.
- History of medical co-morbidity that may result in poor wound healing (i.e. diabetes mellitus, peripheral vascular disease).
- Patients <18 or >80 years of age.
- Patients who are prisoners.
- Mentally unable to sign informed consent.
- Has an uncontrolled illness that, in the opinion of the investigator, is likely to cause the patient to be withdrawn from the trial or would otherwise interfere with interpreting the results of the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: STRATAFIX GROUP
STRATIFIX symmetric PDS Plus #1 will be used to close the capsule following total knee arthroplasty.
The subcutaneous layer will be then closed with simple interrupted knots using number 2-0 braided absorbable sutures (Vicryl), followed by closure of the subcutaneous layer using a number 2-0 monofilament absorbable suture with inverted interrupted knots (Monocryl) followed by the use of steri-strips and adhesive
|
STRATIFIX symmetric PDS Plus; Stratifix knotless suture
|
Placebo Comparator: CONTROL GROUP
The arthrotomy (deep layer) is repaired using Vicryl #1 followed by closure of the intermediate layer with a 2-0 Vicryl and a subcutaneous layer with a 2-0 Monocryl followed by steri-strips and adhesive, following total knee arthroplasty.
|
Vicryl #1
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to Close, Minutes
Time Frame: Day of surgery
|
Time from first needle insertion to complete skin closure per protocol
|
Day of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Wound Complications
Time Frame: 90 days postoperative
|
superficial wound infection, deep wound infection, periprosthetic joint infection, wound hematoma, and wound dehiscence.
|
90 days postoperative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Viktor Krebs, MD, The Cleveland Clinic
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 17-841
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound; Knee
-
University of Missouri-ColumbiaSmith & Nephew, Inc.CompletedWound of Knee | Wound of HipUnited States
-
Indus Hospital and Health NetworkTerminated
-
Germans Trias i Pujol HospitalFundació Institut Germans Trias i PujolUnknownSurgical Wound | Knee DiseaseSpain
-
Rothman Institute OrthopaedicsEnrolling by invitation
-
Spectrum Health HospitalsNovadaq Technologies ULC, now a part of StrykerCompletedLower Extremity Amputation | Wound Healing | Below Knee Amputation | Above Knee AmputationUnited States
-
Brigham and Women's HospitalWithdrawnWound of Knee | Wound of Skin | Non-melanoma Skin Cancer | Skin Graft Complications | Wound of Lower LegUnited States
-
ZipLine Medical Inc.CompletedWound Healing | Arthroplasty, Knee ReplacementUnited States
-
Chinese University of Hong KongRecruitingKnee Arthropathy | Negative Pressure Wound Therapy | Hip ArthropathyHong Kong
-
Foundation for Southwest Orthopedic ResearchCompletedWound Closure | Total Knee Replacement ClosureUnited States
-
Indus Hospital and Health NetworkAga Khan UniversityUnknown
Clinical Trials on STRATIFIX
-
The Cleveland ClinicCompletedWound; HipUnited States
-
Zagazig UniversityCompleted